New methods could spot hidden heart artery disease sooner after transplant
NCT ID NCT03217786
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests better ways to detect early artery narrowing in new hearts after transplant, a condition called cardiac allograft vasculopathy (CAV). About 80 adult heart transplant patients will be followed within their first three months to compare advanced imaging and blood tests against standard methods. The goal is to catch CAV earlier so doctors can treat it before it causes heart failure or death.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIAC ALLOGRAFT VASCULOPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Ottawa Heart Institute
Ottawa, Ontario, K1Y4W7, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug combo shield young hearts from transplant complications?
- Heart transplant patients may soon skip invasive artery checks with new PET scan study
- Could early blood thinners save heart transplants?
- Heart transplant patients get new weapon against hidden artery damage
- Blood test may spot tiny heart blockages in transplant patients